pre-IPO PHARMA

TAG: CEO

Sep 27, 2023

SaNOtize’s Board Appoints Steven Basta as New Chief Executive Officer


Sep 19, 2023

OcuTerra President and CEO Kerrie Brady Named to 2023 PharmaVoice 100 List of Most Inspiring Leaders


Sep 5, 2023

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Advanced Therapies Europe


Aug 29, 2023

Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharmaceuticals, as Independent Chairman


Aug 28, 2023

Akston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City



Aug 23, 2023

FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition


Aug 21, 2023

Rob Scholl Named President and CEO of Textron Specialized Vehicles Inc.; Kriya Shortt Named President and CEO of Textron eAviation


Jul 25, 2023

Pheon Therapeutics Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer


Jul 20, 2023

EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million


Jul 18, 2023

Neumora Therapeutics Names Henry Gosebruch as President and Chief Executive Officer



Jul 17, 2023

Lyndra Therapeutics Announces Leadership Changes, Update on Pivotal Trial Progress


Jul 11, 2023

APIE Therapeutics Appoints Ashwin Datt Chief Executive Officer


Jul 10, 2023

CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr. Lara Sullivan


Jun 29, 2023

Rivus Pharmaceuticals Announces Leadership Transition, Appointment of Jayson Dallas, M.D., as CEO


Jun 23, 2023

Calidi Biotherapeutics Announces Commitment of $25 Million in Series B Funding to Advance Stem Cell-Based Platforms for the Delivery and Potentiation of Oncolytic Viruses to Treat Cancer



Jun 21, 2023

Noema Pharma Appoints Ilise Lombardo, M.D., as Chief Executive Officer


Jun 16, 2023

Biotech Executive Michael Smith Discusses the FDA Drug Development Process with CancerVAX CEO Ryan Davies


Jun 14, 2023

EY Announces Apurva Saraf, President and CEO of Cosette Pharmaceuticals as an Entrepreneur Of The Year 2023 New Jersey Award Winner


Jun 12, 2023

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote on AI in Healthcare at McKenna Institute Digital Innovation Summit


Jun 6, 2023

CancerVAX CEO Ryan Davies and Raymond Vennare Discuss the Cancer Fighting Role of Universities



Jun 5, 2023

Seneca Therapeutics, Inc. Appoints Cuong Do to its Board of Directors


Jun 5, 2023

Altoida Appoints Marc Jones as Chief Executive Officer


Jun 1, 2023

Excision BioTherapeutics Appoints Former Pfizer Chairman and CEO Jeffrey B. Kindler to its Board of Directors


Jun 1, 2023

Aerami Therapeutics Appoints Joshua Ziel as COO and Interim CEO and Expands Management Team as Lead Asset AER-901 (inhaled imatinib) Advances Toward Phase 2 in Pulmonary Hypertension


May 30, 2023

Medicines360 Appoints Andrea Olariu, MD, PhD as Chief Executive Officer



May 24, 2023

HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer USA - English France - Français


May 23, 2023

Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer and Other Leadership Appointments


May 17, 2023

Biotech Entrepreneur and Venture Capitalist Dinesh Patel Discusses Therapeutics and Medical Devices with CancerVAX CEO Ryan Davies


May 12, 2023

Insilico Medicine Founder and CEO to Give Keynote on Disease Modeling with AI at PEGS Boston


May 11, 2023

Tevogen Bio Expresses Gratitude as CEO is Named Recipient of Boy Scouts of America Distinguished Citizen Award



May 8, 2023

Inceptor Bio Appoints Matthias Schroff, PhD, as Chief Executive Officer


May 5, 2023

Aerami Therapeutics Mourns the Sudden Loss of Chief Executive Officer Lisa Yañez


May 1, 2023

Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer


Apr 27, 2023

Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO


Apr 20, 2023

Former Pfizer Legal Counsel Discusses Gene Therapy with CancerVAX CEO Ryan Davies



Apr 12, 2023

Gennao Bio Announces Appointment of Christopher Duke as Chief Executive Officer


Apr 12, 2023

CancerVAX CEO Ryan Davies Discusses Cancer Research with Leading Pediatric Hematologic Oncologist


Mar 30, 2023

Mathai Mammen, M.D., Ph.D., to Join FogPharma as Chairman, President and Chief Executive Officer


Mar 24, 2023

CancerVax CEO Ryan Davies Speaks with University of Utah Chemistry Professor about the Future of Therapeutic Research


Mar 23, 2023

ICR Hosts SAB Biotherapeutics CEO Eddie Sullivan on the Welcome to the Arena Podcast



Mar 22, 2023

Leading Diabetes Researcher Speaks on his Groundbreaking ‘Edmonton Protocol’ with CancerVAX CEO Ryan Davies


Mar 21, 2023

Wugen Announces CEO Transition


Mar 20, 2023

CancerVAX CEO Ryan Davies Sits Down with Oncology Research Leader


Mar 13, 2023

Bryn Pharma Announces Appointment of Sandy Loreaux as CEO


Mar 7, 2023

AuraVax Therapeutics Appoints Industry Veteran Joseph Sullivan as its Inaugural CEO



Feb 16, 2023

Lutris Pharma to Present at the 16th Annual European Life Sciences CEO Forum in March


Feb 9, 2023

EicOsis Announces the Appointment of Dr. Cindy McReynolds as CEO


Feb 3, 2023

Microbion Corporation CEO to Present at the 2023 BIO CEO and Investor Conference


Feb 2, 2023

Nanoscope Therapeutics to Present at the BIO CEO and Investor Conference


Jan 31, 2023

Casma Therapeutics Announces CEO Transition



Jan 30, 2023

Therapeutic Solutions International Spin Off Res Nova Bio Announces Recruitment of President and Chief Executive Officer


Jan 30, 2023

Halia Therapeutics to Present at the 2023 BIO CEO and Investor Conference


Jan 26, 2023

KeifeRx to Present at the BIO CEO and Investor Conference


Jan 24, 2023

Biomica CEO to Participate in Panel Discussion at 7th European Annual Microbiome Movement USA - English Israel - English


Jan 24, 2023

Biomica CEO to Participate in Panel Discussion at 7th European Annual Microbiome Movement



Jan 10, 2023

NKGen Biotech Appoints Paul Y. Song, MD as Chief Executive Officer


Jan 9, 2023

AIVITA Biomedical CEO Dr. Hans Keirstead Joins Human Immunome Project Board of Directors


Jan 6, 2023

Intergalactic Therapeutics Appoints Theresa G.H. Heah, M.D., M.B.A., as Chief Executive Officer


Jan 5, 2023

Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics


Jan 3, 2023

ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics



Dec 28, 2022

Biomica CEO to Attend the JP Morgan Healthcare Week in San Francisco between January 9-11, 2023 USA - English USA - English


Dec 28, 2022

Biomica CEO to Attend the JP Morgan Healthcare Week in San Francisco between January 9-11, 2023


Dec 21, 2022

Aerami Therapeutics Appoints Lisa Yañez as Chief Executive Officer


Dec 19, 2022

American Gene Technologies Appoints Dr. Marcus A. Conant as Special Advisor to the CEO


Dec 13, 2022

Chimeron Bio Welcomes Kevin Heyeck as New CEO



Dec 7, 2022

Amber Salzman, Ph.D., CEO of Epic Bio, Recognized by Endpoints News as One of the Most Influential Women in Biopharma RandD


Nov 21, 2022

Vividion Therapeutics Recognized as a San Diego area ‘Top Workplaces 2022’ Award Winner by the San Diego Union-Tribune


Nov 14, 2022

Biomica CEO to Participate in an Industry Panel Discussion at Microbiome Connect USA 2022 Summit USA - English USA - English


Nov 14, 2022

Alice Zhang, CEO and Co-founder of Verge Genomics, Recognized Today by Both Fortune and Fierce Biotech as a Pioneer in AI-Driven Drug Discovery


Nov 14, 2022

Biomica CEO to Participate in an Industry Panel Discussion at Microbiome Connect USA 2022 Summit



Nov 9, 2022

Oblique Therapeutics is delighted to announce the appointment of Christer Nordstedt M.D. PhD. as Chief Executive Officer USA - English USA - English


Nov 4, 2022

Cambrian Biopharma CEO James Peyer Named 2022 "BioTech Company CEO of the Year" By BioTech Breakthrough


Nov 1, 2022

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at World Immunotherapy Congress Europe


Oct 27, 2022

Tevogen Bio CEO Ryan Saadi and CSO Neal Flomenberg share White House concerns about emerging COVID-19 variants and impact on immunocompromised patients, and express commitment to accelerate development of company’s investigational COVID-19 therapy


Oct 26, 2022

Propanc Biopharma’s CEO to Present at Sidoti and Company Micro-Cap Virtual Investor Conference



Oct 25, 2022

AIVITA Biomedical CEO Dr. Hans Keirstead Leads Multidisciplinary Team of Scientists Invited by Dalai Lama to Discuss Consciousness


Oct 20, 2022

Vivera Welcomes Healthcare Founder and CEO Lea Ramirez to its Advisory Board


Oct 20, 2022

Arbor Biotechnologies’ CEO Devyn Smith, Ph.D., Elected as Chairman of the Alliance for Regenerative Medicine


Oct 17, 2022

Avalyn Pharma Appoints Lyn Baranowski Chief Executive Officer


Oct 12, 2022

Verge Genomics Honored by Goldman Sachs for Entrepreneurship



Oct 12, 2022

Propanc Biopharma’s CEO to Attend 43rd Meeting of the European Organization of Research and Treatment of Cancer (EORTC), Dec 15 - 17


Oct 12, 2022

Tevogen Bio Expresses Gratitude for 2023 Nobel Peace Prize Nomination of the Company and its Founding CEO Ryan Saadi in Recognition of its Novel Business Model to Alleviate Health Inequality


Oct 5, 2022

Valitor Announces the Closing of its Series B Financing and Names Steven Lo as Chief Executive Officer


Oct 4, 2022

InCarda Therapeutics Announces Execution of Planned CEO Transition to Drive Next Phase of Corporate Growth


Oct 4, 2022

Chroma Medicine Welcomes Spark Therapeutics Co-Founder and Former Founding CEO Jeff Marrazzo to Board of Directors



Sep 22, 2022

Jeff Munn Joins L2 Portfolio Company Jurassic Quest as CEO to Shepherd North America’s Largest Dinosaur Enterprise


Sep 20, 2022

Q32 Bio, a Clinical Stage Biotechnology Company Focused on Therapeutics that Restore Immune Homeostasis, Announces CEO Transition


Sep 14, 2022

AIVITA Biomedical CEO Dr. Hans Keirstead Wins Innovator of the Year Award


Sep 14, 2022

Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering


Sep 13, 2022

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote Address at United Nations 'AI for Good' Meeting



Sep 7, 2022

STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer


Aug 25, 2022

HemoShear Therapeutics Appoints Brian Wamhoff, PhD, Interim Chief Executive Officer


Aug 22, 2022

Tessa Therapeutics Appoints Thomas Willemsen as President and CEO


Aug 11, 2022

PsiOxus Therapeutics Appoints Howard Davis, Ph.D. as Chief Executive Officer


Aug 11, 2022

NextRNA Therapeutics Names Dominique Verhelle as CEO and Expands Leadership Team



Aug 1, 2022

Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer USA - English USA - Français Nederland - Nederlands


Jul 25, 2022

Flare Therapeutics Appoints Amit Rakhit, M.D. as President and Chief Executive Officer


Jul 20, 2022

CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Targeting Platform and Advance Lead Programs into the Clinic


Jul 18, 2022

Avet Pharmaceuticals Names George Svokos President and Chief Executive Officer


Jul 18, 2022

ROME Therapeutics Appoints Industry Veteran Jeff Hatfield as Chair of Board of Directors



Jul 12, 2022

Propanc Biopharma’s CEO Believes Lead Asset Could Unlock Value as PRP Advances to Phase I, First-In-Human Study in Advanced Cancer Patients


Jul 11, 2022

Meissa Vaccines Appoints Frank Glavin Chief Executive Officer


Jul 5, 2022

Propanc Biopharma’s CEO Comments on the 39 Granted Patents and 26 Patent Applications Under Examination in Key Global Jurisdictions


Jun 28, 2022

Merakris CEO To Discuss Dermacyte Development Program As Part of Advanced Wound Care Summit Panel in July


Jun 27, 2022

Steven Kelly, President and CEO of Carisma Therapeutics, Named Ernst and Young Entrepreneur of the Year 2022 Greater Philadelphia



Jun 27, 2022

Nanoscope Therapeutics CEO Sulagna Bhattacharya Named Winner of EY Entrepreneur Of The Year 2022 Central Plains Award


Jun 16, 2022

Panorama Medicine Appoints Dr. Haishan Xiong as Chief Executive Officer


Jun 14, 2022

Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer


Jun 2, 2022

Michael Severino, M.D., Joins Flagship Pioneering-Founded Tessera Therapeutics as Chief Executive Officer


May 31, 2022

BioAge CEO to Lead a Panel Discussion at the BIO 2022 Conference: “Targeting Aging Pathways to Treat Chronic Disease” — June 14, 2022, 11 AM



May 26, 2022

Alchemab Appoints Young T. Kwon as Chief Executive Officer


May 9, 2022

Adimab Announces Promotions of New Chief Executive Officer and President


Apr 19, 2022

eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer


Apr 18, 2022

Paul Laikind, PhD, Joins Stemson Therapeutics Board of Directors


Apr 18, 2022

Fore Biotherapeutics Appoints Matthew E. Ros as Chief Executive Officer



Apr 12, 2022

Akston Biosciences CEO to Present at the World Vaccine Congress


Apr 8, 2022

AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board and Miss Sheng Liu as a New Board Member


Apr 6, 2022

Propanc Biopharma’s CEO Expresses Concern Over Disruption to Cancer Care During Global Pandemic


Mar 28, 2022

Ankyra Therapeutics Appoints Howard L. Kaufman, MD as President and Chief Executive Officer


Mar 16, 2022

Propanc Biopharma’s CEO Believes Proenzyme Therapy May Become the Healthcare Solution of Choice for Treating Cancerous Solid Tumors



Mar 10, 2022

Morningside Ventures Launches Adiso Therapeutics to Advance Novel Therapies for Inflammatory Diseases


Mar 9, 2022

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Festival of Biologics


Mar 4, 2022

GI Innovation Recruits Chief Executive Officer Byung-Geon Rhee Former CEO of GC Pharma, SCM Lifescience Corp.


Mar 3, 2022

Adrestia Appoints Robert Johnson as Chief Executive Officer


Mar 1, 2022

Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease



Feb 23, 2022

Mnemo Therapeutics ernennt Robert LaCaze zum Chief Executive Officer Deutschland - Deutsch USA - English


Feb 23, 2022

Mnemo Therapeutics Names Robert LaCaze as Chief Executive Officer


Feb 23, 2022

Complement Therapeutics Ltd raises EUR 5 Million Seed Financing by BGV and Forbion and appoints Dr Rafiq Hasan as CEO


Feb 23, 2022

Mnemo Therapeutics Names Robert LaCaze as Chief Executive Officer USA - English Deutschland - Deutsch


Feb 23, 2022

Mnemo Therapeutics ernennt Robert LaCaze zum Chief Executive Officer USA - English USA - English



Feb 22, 2022

Cumulus Oncology Secures £4.1m ($5.6m) Investment Led by Eos Advisory


Feb 18, 2022

Azurity Pharmaceuticals Announces Richard Blackburn as New CEO


Feb 17, 2022

Lyra Therapeutics Appoints Harlan W. Waksal, MD, as Executive Chairman


Feb 17, 2022

Nanoscope Therapeutics CEO Sulagna Bhattacharya Elected to BIO Emerging Companies Section Governing Board


Feb 17, 2022

Ribon Therapeutics, a Clinical Stage Biotechnology Company Targeting Stress Support Pathways in Cancer and Inflammation, Announces CEO Transition for Its Next Phase of Growth



Feb 16, 2022

AI Therapeutics Appoints Brigette Roberts, M.D., as Chief Executive Officer


Feb 16, 2022

Actym Therapeutics CEO Dr. Christopher Thanos named one of the "Top 25 Biotech CEOs of 2022"


Feb 16, 2022

Cambrian Biopharma Announces Licensing Agreement to Develop Selective mTOR Inhibitors


Feb 15, 2022

Renibus Therapeutics Announces Appointment of Frank Stonebanks as CEO and $35 Million Series A Funding


Feb 14, 2022

Vivacitas Oncology to Present at the 2022 BIO CEO and Investor Conference



Feb 11, 2022

Nanoscope Therapeutics to present at 2022 BIO CEO and Investor Conference


Feb 11, 2022

Immunomic Therapeutics to present at the BIO CEO and Investor Conference 2022


Feb 11, 2022

Syncromune, Inc. to Present at the 2022 BIO CEO and Investor Conference


Feb 10, 2022

Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer


Feb 10, 2022

Elpiscience to Participate in Cross-Pacific Collaboration Panel at BIO CEO and Investor Conference



Feb 9, 2022

CytoImmune Therapeutics to Participate in the 2022 BIO CEO and Investor Conference and the SVB Leerink Global Healthcare Conference


Feb 9, 2022

Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. as CEO


Feb 7, 2022

KeifeRx to Present at 2022 BIO CEO and Investor Conference


Feb 7, 2022

Aruvant to Participate in the 2022 BIO CEO and Investor Gene Therapy Panel on February 16, 2022


Feb 3, 2022

GRO Biosciences to Present at 2022 BIO CEO and Investor Conference



Jan 13, 2022

Aristea Therapeutics Announces Key Leadership Appointments to Advance Its Clinical Pipeline


Jan 12, 2022

Nirogy Therapeutics Appoints Simon Pedder, Ph.D., as Chief Executive Officer


Jan 11, 2022

Nine Square Therapeutics Appoints Robert Paul as CEO


Jan 10, 2022

ReCode Therapeutics Appoints Shehnaaz Suliman, M.D., MBA, M.Phil., as Chief Executive Officer


Jan 7, 2022

Paul Edalat, CEO of Vivera, Joins Forbes Business Council



Jan 5, 2022

Alzheon to Present at H.C. Wainwright Bioconnect Conference on January 10, 2022


Jan 5, 2022

Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO


Jan 4, 2022

OnQuality Pharmaceuticals Reports Topline Data from Phase 2 Trial of Treatment for Cancer Therapy Induced Skin Toxicity that Met Expectations


Dec 20, 2021

Versantis Appoints Mark Fitzpatrick, Seasoned Biotech Executive, as its New CEO


Dec 7, 2021

Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO



Nov 29, 2021

Philip Chamberlain Named as Chief Executive Officer of Neomorph


Nov 16, 2021

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote At Vaccine World Asia Congress


Nov 15, 2021

CORRECTING and REPLACING Penrose TherapeuTx Appoints Pharmaceutical Leader David Sherris, Ph.D., as President and Chief Executive Officer


Nov 10, 2021

CytoImmune Therapeutics Appoints Renowned Oncologist and Immunologist as New Chief Executive Officer


Nov 8, 2021

AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe



Nov 8, 2021

Marengo Therapeutics Launches with $80M from ATP, Appoints CEO Zhen Su, MD, to Deliver Breakthrough Cancer Treatments Using Its Selective T Cell Activation Repertoire (STAR) Platform


Oct 28, 2021

BioTheryX Announces Appointment of Philippe Drouet as Chief Executive Officer


Oct 27, 2021

Tevogen Bio CEO Dr. Ryan Saadi Appointed to Yale School of Public Health Leadership Council


Oct 27, 2021

Cytovation announces the appointment of Bo Jesper Hansen as Strategic Advisor


Oct 19, 2021

Artizan Biosciences Announces Appointment of Dr. Bridget Martell as President and Chief Executive Officer



Oct 18, 2021

NFlection Therapeutics Appoints William Hodder as CEO and Expands Leadership Team to Accelerate Development of Targeted Treatments for Rare Diseases


Oct 18, 2021

DiscGenics Honored by Goldman Sachs for Entrepreneurship


Oct 14, 2021

Micreos appoints Matt Regan as CEO of its Pharmaceutical business


Oct 14, 2021

Kojin Therapeutics Announces Luba Greenwood as Chief Executive Officer


Oct 11, 2021

Ensoma Appoints Cell and Gene Therapy Pioneer Emile Nuwaysir, Ph.D., as Chief Executive Officer



Oct 4, 2021

AIVITA Biomedical CEO Dr. Hans Keirstead to Give Keynote Address at Advanced Therapies Congress in London


Sep 30, 2021

RGENIX Announces Company Name Change to Inspirna and Expands Board of Directors with Appointment of Pharma Veteran Dieter Weinand


Sep 30, 2021

Currax Pharmaceuticals Hosted Ribbon-Cutting Ceremony to Mark the Opening of its Nashville Headquarters


Sep 22, 2021

Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer


Sep 21, 2021

Vigeo Therapeutics Provides Clinical Update for Lead Asset VT1021 and Welcomes New Chief Executive Officer



Sep 21, 2021

ImmuneID Appoints Veteran Biotech Executive James S. Scibetta as CEO


Sep 17, 2021

Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds


Sep 15, 2021

Cognito Therapeutics CEO Brent Vaughan to Speak at CODE Conference 2021


Sep 13, 2021

Alzheon to Present at H.C. Wainwright Annual Global Investment Conference on September 13, 2021


Sep 8, 2021

ReForm Biologics Names Industry Veteran Jeff Hackman as President and Chief Executive Officer



Sep 2, 2021

Civetta Therapeutics Announces the Appointment of Christopher D. Roberts, Ph.D., as CEO


Aug 31, 2021

Korro Bio Chief Executive Officer Ram Aiyar, Ph.D., MBA, to Participate in September Investor Conferences


Aug 26, 2021

President and CEO of Rafael Pharmaceuticals, Sanjeev Luther, to Present at the 11th Annual World Orphan Drug Congress USA 2021


Aug 25, 2021

Forge Biologics Announces Key Hires in CDMO Operations and Medical Affairs, Company Presentations at World Orphan Drug Congress


Aug 17, 2021

Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer



Aug 17, 2021

AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO


Aug 12, 2021

Pharma Two B Appoints David S. Tierney, M.D. as the Company’s Chief Executive Officer


Aug 10, 2021

MoonLake Immunotherapeutics appoints former Kymab CEO Simon Sturge as Chairman and Spike Loy to the Board of Directors USA - English Deutschland - Deutsch France - Français España - español


Aug 10, 2021

MoonLake Immunotherapeutics appoints former Kymab CEO Simon Sturge as Chairman and Spike Loy to the Board of Directors USA - English USA - Deutsch USA - Français USA - español


Aug 10, 2021

MoonLake Immunotherapeutics ernennt den ehemaligen Kymab-CEO Simon Sturge zum Vorsitzenden und Spike Loy zum Mitglied des Verwaltungsrats Deutschland - Deutsch USA - English France - Français España - español



Aug 5, 2021

Kallyope Announces CEO Transition as Company Advances to its Next Stage of Growth


Aug 3, 2021

Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors


Jul 28, 2021

Asceneuron CEO Dirk Beher to Speak at Alzheimer's Association International Conference


Jul 27, 2021

Prokarium Appoints Kristen Albright as Chief Executive Officer


Jul 27, 2021

ForwardVue Pharma Appoints Bob Katz as Chief Executive Officer



Jul 21, 2021

Axon Therapies Announces Chad Hoskins As Chief Executive Officer


Jul 20, 2021

Elevar Therapeutics Announces CEO Transition and New Board Appointment


Jul 15, 2021

T-Cypher Bio announces the appointment of Thomas Lars Andresen as Chief Executive Officer


Jul 7, 2021

Scorpion Therapeutics Announces New CEO Axel Hoos, M.D., Ph.D.


Jul 7, 2021

Adcendo Appoints Michael Pehl as Chief Executive Officer



Jul 6, 2021

CinCor Pharma Appoints Marc de Garidel as Chief Executive Officer


Jul 6, 2021

Medicines360 Appoints Tina Raine-Bennett, MD, MPH, FACOG, as Chief Executive Officer


Jul 1, 2021

MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO USA - English France - Français España - español Deutschland - Deutsch


Jul 1, 2021

MoonLake Immunotherapeutics ernennt Jorge Santos da Silva zum CEO und Matthias Bodenstedt zum CFO Deutschland - Deutsch France - Français España - español USA - English


Jul 1, 2021

MoonLake Immunotherapeutics appoints Jorge Santos da Silva as CEO and Matthias Bodenstedt as CFO USA - English USA - Français USA - español USA - Deutsch



Jun 30, 2021

Azafaros Appoints Stefano Portolano, M.D., as Chief Executive Officer


Jun 29, 2021

Orbit Discovery Appoints Dr Neil Butt as Chief Executive Officer


Jun 24, 2021

IgGenix Announces Jessica Grossman, M.D., as Chief Executive Officer


Jun 23, 2021

Immunicom Presentation Defines Breakthrough Subtractive Therapy’s Role in “New Era” Cancer Care at LSI’s Annual Emerging MedTech Summit


Jun 22, 2021

CORRECTING and REPLACING Alchemab Therapeutics Appoints Douglas A. Treco, PhD as Chief Executive Officer



Jun 17, 2021

LENZ Therapeutics Debuts With $47 Million Series A Financing


Jun 9, 2021

Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer


Jun 8, 2021

Greg Kunst Appointed CEO of Aurion Biotech


Jun 7, 2021

Hawaii Biotech President And CEO Elliot Parks Stepping Down


Jun 1, 2021

Ambys Medicines Appoints Ronald Park, M.D., Chief Executive Officer



Jun 1, 2021

Macrophage Pharma Appoints Dr Venkat Reddy as Chief Executive Officer


May 27, 2021

Betagenon AB announces new CEO and new Chairman of the Board


May 26, 2021

NiKang Therapeutics Announces Completion of $200 Million Series C Financing to Advance Highly Differentiated Small Molecules Addressing Difficult-to-Drug Targets


May 25, 2021

Korro Bio Chief Executive Officer Ram Aiyar, Ph.D., MBA, to Present at 2021 Jefferies Virtual Healthcare Conference


May 21, 2021

Chief Executive Officer Alessandro Riva, M.D., To Leave Ichnos Sciences



May 18, 2021

Aerovate Therapeutics Appoints Timothy Noyes as Chief Executive Officer


May 14, 2021

Cytovia Therapeutics CEO Dr. Daniel Teper to Present at Two Upcoming Conferences


May 11, 2021

LianBio Appoints Yizhe Wang, Ph.D., as Chief Executive Officer


May 4, 2021

Azitra Appoints Francisco Salva as Chief Executive Officer


May 4, 2021

CatalYm Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Officer



May 1, 2021

Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO


Apr 28, 2021

Bantam Pharmaceutical Appoints Industry Veteran Michael Stocum as President and Chief Executive Officer


Apr 26, 2021

Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer


Apr 26, 2021

Fountain Therapeutics Appoints William L. Greene, M.D. Chief Executive Officer


Apr 20, 2021

Cellphire Therapeutics Names Michael Gaffney as Company's New CEO



Apr 20, 2021

Israel's Kamada forges ahead with development of new anti-Covid immunoglobulin therapy in partnership with Kedrion Biopharma of Italy USA - English USA - English France - Français Deutschland - Deutsch


Apr 20, 2021

Israel's Kamada forges ahead with development of new anti-Covid immunoglobulin therapy in partnership with Kedrion Biopharma of Italy USA - English Israel - English USA - Français USA - Deutsch


Apr 15, 2021

Tectonic Therapeutic Launches with $80 Million Series A Financing to Transform the Discovery of Novel G-Protein Coupled Receptor (GPCR)-Targeted Therapies


Apr 14, 2021

Wugen Appoints Daniel Kemp, Ph.D., as Chief Executive Officer


Apr 12, 2021

Francesco Maria Lavino appointed Chief Executive Officer of F2G Ltd



Apr 7, 2021

Acanthamoeba Keratitis, Leishmaniasis and Dry Nose discussed with Profounda’s CEO Todd MacLaughlan


Apr 6, 2021

Mineralys Therapeutics Closes $40 Million Series A Funding


Mar 31, 2021

KeifeRx Builds Leadership Team with Announcement of Chris Hoyt as Chief Executive Officer


Mar 29, 2021

Paul Fonteyne Joins Amylyx Pharmaceuticals Board of Directors


Mar 24, 2021

Inotrem Bolsters Leadership Team With the Appointment of Sven Zimmermann as New CEO



Mar 23, 2021

Provectus Algae Appoints CEO of Senti Biosciences to Board to Aid Advancement of High-Throughput Synthetic Biology Platform


Mar 23, 2021

SiteOne Therapeutics Names Scientific Founder John Mulcahy, Ph.D., as Chief Executive Officer


Mar 23, 2021

Humacyte CEO Dr. Laura Niklason and Alpha Healthcare CEO Rajiv Shukla to Present at CED Venture Connect 2021 Online Summit


Mar 18, 2021

Delix Therapeutics Names Mark Rus as Chief Executive Officer


Mar 18, 2021

Xcovery Announces the Appointment of Giovanni Selvaggi as Chief Executive Officer



Mar 16, 2021

Be Bio Announces Appointment of Cell and Gene Therapy Veterans Joanne Smith-Farrell, Ph.D., as Chief Executive Officer and Rick Morgan, Ph.D., as Chief Scientific Officer


Mar 15, 2021

Aulos Bioscience Appoints Aron Knickerbocker as CEO USA - English USA - English USA - English


Mar 15, 2021

Aulos Bioscience Appoints Aron Knickerbocker as CEO


Mar 15, 2021

Aulos Bioscience Appoints Aron Knickerbocker as CEO USA - English USA - English


Mar 9, 2021

Alzheon to Present at H.C. Wainwright Global Life Sciences Conference on March 9, 2021



Mar 5, 2021

Korro Bio Chief Executive Officer Ram Aiyar, Ph.D., MBA, to Present at Upcoming Conferences


Mar 5, 2021

PACT Pharma Announces Planned Retirement of CEO Alex Franzusoff; Veteran Biotech Executive Scott Garland Named as Successor


Mar 4, 2021

AIVITA Biomedical CEO Hans Keirstead Receives 2021 Global Humanitarian Award


Feb 24, 2021

Alzheon CEO Presents Overview of Oral Anti-Amyloid ALZ-801 Phase 3 Program at 9th Neurodegenerative Drug Development Summit


Feb 24, 2021

EpiEndo Pharmaceuticals Appoints Maria Bech as New Chief Executive Officer to Support Move into Clinical Development



Feb 23, 2021

Anokion Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer


Feb 22, 2021

NovellusDx Establishes Fore Biotherapeutics U.S. as its Operating Company in the United States and Appoints Dieter Weinand as Chairman of the Board and Usama Malik as Chief Executive Officer and Director of the Board


Feb 11, 2021

Cytocom to Present at BIO CEO and Investor Digital Conference


Feb 8, 2021

jCyte Announces Promotion of Dr. Shannon Blalock to Chief Executive Officer


Feb 4, 2021

Catamaran Bio Announces Appointment of Dr. Alvin Shih as President and Chief Executive Officer



Feb 2, 2021

Immunomic Therapeutics’ CEO to present at the BIO CEO and Investor Digital Conference


Feb 1, 2021

Codagenix's CEO to Present Update on COVI-VAC During New York Academy of Sciences Event, "Quest for a COVID-19 Vaccine"


Feb 1, 2021

MOMA Therapeutics Appoints Asit Parikh, M.D., Ph.D. as President and Chief Executive Officer


Feb 1, 2021

OncoNano Medicine Announces Martin Driscoll as Chief Executive Officer


Jan 27, 2021

ViaCyte Appoints Michael Yang President and CEO and Provides Company Update



Jan 26, 2021

Arcellx Appoints Rami Elghandour as Chairman and Chief Executive Officer


Jan 25, 2021

Aspen Neuroscience Announces Appointment of Damien McDevitt, PhD as President and Chief Executive Officer


Jan 25, 2021

Nanobiotix Subsidiary Curadigm Secures New Collaboration Agreement With Sanofi Focused on Gene Therapy Pipeline


Jan 22, 2021

Xalud Therapeutics Appoints Diem Nguyen, Ph.D., as Chief Executive Officer


Jan 21, 2021

Trishula Therapeutics Appoints Anil Singhal as Chief Executive Officer



Jan 19, 2021

T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer and Chief Financial Officer


Jan 19, 2021

Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference


Jan 19, 2021

Receptor Life Sciences Names Successful Pharmaceutical Industry Executive, Mark Theeuwes, President and Chief Executive Officer


Jan 11, 2021

Louis Pascarella Appointed Chief Executive Officer of Innocoll


Jan 11, 2021

Humacyte CEO Dr. Laura Niklason to Present at J.P. Morgan Healthcare Conference January 11



Jan 11, 2021

Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases


Jan 8, 2021

Ginkgo Bioworks CEO to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 7, 2021

BioTheryX Appoints Robert F. Williamson, III as President and Chief Executive Officer


Jan 7, 2021

Abcuro Raises $42 Million in Series A-1 Financing, Appoints John B. Edwards as Executive Chair of the Board of Directors and David de Graaf, Ph.D. as Chief Executive Officer


Jan 5, 2021

Immunomic Therapeutics’ CEO to present at the 13th Annual Biotech Showcase Digital Event



Jan 5, 2021

Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen LaPorte


Jan 5, 2021

IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic Viruses to Treat Solid Tumors


Jan 5, 2021

Pharma Two B Appoints Sheila Oren, M.D., M.B.A., as Chief Executive Officer


Jan 5, 2021

Artiva Biotherapeutics Announces Appointment of Dr. Fred Aslan as President and CEO


Jan 5, 2021

CSG Begins New Era of Growth Under Newly Appointed CEO Brian Shepherd



Dec 21, 2020

Graphite Bio Appoints Pharmaceutical Industry Veterans to Board of Directors


Dec 21, 2020

Atomwise Announces Growing Portfolio of Joint Venture Companies


Dec 9, 2020

Cognito Therapeutics Appoints Industry Pioneer Brent Vaughan as Chief Executive Officer


Dec 8, 2020

Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments


Dec 7, 2020

Chimeron Bio Appoints CEO of Evox Therapeutics and Former CSO of Moderna, Dr. Antonin de Fougerolles to Its Scientific Advisory Board



Dec 4, 2020

Takashi Nagao Appointed President and Chief Executive Officer of Medicago


Dec 1, 2020

Antios Therapeutics Appoints Gregory T. Mayes Chief Executive Officer


Dec 1, 2020

Immunomic Therapeutics’ CEO to Present at the 2nd Annual Glioblastoma Drug Development Summit


Nov 23, 2020

Penrose TherapeuTx Appoints Business Leader Mark de Souza as Chief Executive Officer to Help Drive New Innovations in Oncology


Nov 20, 2020

Humacyte Appoints Founder Laura Niklason MD, PhD as President and Chief Executive Officer



Nov 18, 2020

Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer


Nov 10, 2020

Korro Bio Appoints Ram Aiyar, Ph.D., MBA, as Chief Executive Officer


Nov 10, 2020

Apnimed Further Strengthens Leadership Team and Board of Directors


Oct 28, 2020

UNION therapeutics appoints Dr. Kim Kjoeller as Chief Executive Officer and further strengthens leadership by appointing Dr. Günter Ditzinger as Chief Technology Officer


Oct 26, 2020

Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0



Oct 22, 2020

Vycellix CEO to Present its Universal Cell Program (VY-UC) for Off-the-Shelf NK Cell Therapy at Allogeneic Cell Therapies Summit


Oct 22, 2020

Allonnia Launches from Ginkgo Bioworks' Ferment Consortium with $40M Series A to Address Critical Problems in Waste Remediation with Synthetic Biology, Appoints Nicole Richards as CEO


Oct 21, 2020

Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Publicly Listed Leader in Oncology Drug Development


Oct 21, 2020

SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer


Oct 20, 2020

Immunomic Therapeutics’ CEO to Present at the 5th International Virtual Conference on Cancer Research and Development 2020



Oct 20, 2020

Immunicom CEO Amir Jafri Named a Top Healthcare Leader in CEO Today Healthcare Awards


Oct 19, 2020

ONK Therapeutics Closes New Financing and Appoints Chris Nowers as CEO


Oct 14, 2020

Ambys Medicines Expands Board of Directors with Appointment of Jennifer Cook


Oct 14, 2020

Goldfinch Bio Honored by Goldman Sachs for Entrepreneurship


Oct 14, 2020

CUREMARK Honored by Goldman Sachs for Entrepreneurship



Oct 14, 2020

AffaMed Therapeutics Announces Merger with EverInsight Therapeutics and Appoints Dayao Zhao, M.D., Ph.D. as CEO


Oct 6, 2020

Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies


Oct 6, 2020

Walden Biosciences Launches to Transform the Treatment of Kidney Disease


Oct 5, 2020

Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President


Oct 1, 2020

AZTherapies Announces Leadership Transition, Appointing Marc de Garidel Chief Executive Officer and Member of the Board of Directors



Oct 1, 2020

Dutch Vico Therapeutics strengthens leadership team with the appointment of Rupert Sandbrink as Chief Medical Officer and Anders Hinsby as Independent Director


Sep 30, 2020

Tarveda Therapeutics Appoints Brian Roberts as Chief Executive Officer


Sep 29, 2020

Immunomic Therapeutics’ CEO to Participate in Panel at MD Life Sciences’ Bio Innovation Conference Meeting 2020


Sep 16, 2020

Graphite Bio Launches with $45 Million Series A Financing


Sep 16, 2020

Volastra Therapeutics Appoints Charles Hugh-Jones as Chief Executive Officer



Sep 10, 2020

Sermonix CEO David Portman to Participate in Women’s Health Innovation Virtual Summit


Sep 9, 2020

MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer English English


Sep 9, 2020

MetaboMed Appoints Ali Fattaey, Ph.D. as Chief Executive Officer USA - English USA - English USA - English USA - English USA - English USA - English USA - English USA - English España - español España - español


Sep 8, 2020

Andrew Hirsch Named Chief Executive Officer of C4 Therapeutics


Aug 17, 2020

Seneca Therapeutics Announces Appointment of James M. Hussey as Chief Executive Officer and a Director



Aug 12, 2020

PIC Therapeutics Appoints Dr. Katherine Bowdish as Chief Executive Officer


Aug 10, 2020

Vycellix CEO to Present Next-Generation Universal Cell Platform to Optimize Allogeneic Cell Therapies at ‘Innate Killer Summit’


Aug 6, 2020

Mycovia Pharmaceuticals CEO Patrick Jordan Named 2020 Life Sciences CEO of the Year by Triangle Business Journal


Aug 3, 2020

NBE-Therapeutics Appoints Bertrand Damour as Chief Executive Officer


Jul 20, 2020

Notch Therapeutics Appoints David Main as President and Chief Executive Officer to Advance the Company's Novel Gene-Edited, iPSC-Derived Immune Cell Therapeutics



Jul 1, 2020

AIVITA Biomedical CEO Hans Keirstead Named to “20 in 2020” by Consulate General of Canada for Contributions to COVID-19 Research


Jul 1, 2020

FortisTCI Names First Female President and CEO


Jun 17, 2020

Verve Therapeutics CEO Sekar Kathiresan, M.D., to Give Keynote Presentation at the International Society for Stem Cell Research (ISSCR) 2020 Virtual Annual Meeting


Jun 15, 2020

Abcentra Names Kevin B. Bacon, Ph.D. Chief Executive Officer


Jun 11, 2020

Juvenescence Appointment of CEO for Souvien and Epigenetic Division



Jun 10, 2020

Curadigm Announces Publication of Results Using Proprietary Nanoprimer to Improve RNA Therapeutics in Collaboration With the Langer Lab


Jun 10, 2020

NANOBIOTIX Spinoff Curadigm Validates Novel Nanoprimer Technology in RNA Therapeutics


Jun 9, 2020

Metacrine Appoints Pharmaceutical Business and RandD Executive, Preston Klassen, M.D., MHS, as President and Chief Executive Officer


Jun 9, 2020

Versant Ventures Launches Lycia Therapeutics with $50 Million


Jun 8, 2020

SAB Biotherapeutics President and CEO Eddie J. Sullivan, PhD, Featured on COVID-19 Panel at BIO Digital 2020



May 28, 2020

Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity


May 27, 2020

Kinnate Biopharma Appoints Nima Farzan as Chief Executive Officer


May 22, 2020

Silverback Therapeutics Announces Appointment of Veteran Executive Laura Shawver, Ph.D. as President and CEO


May 5, 2020

Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO


May 4, 2020

Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer



Apr 15, 2020

Cardurion Pharmaceuticals Announces Appointment of Peter Lawrence as President and Chief Executive Officer


Mar 26, 2020

Herdís Fjeldsted temporarily leaves the board of directors of Arion Bank and becomes CEO of Valitor


Mar 24, 2020

Triumvira Immunologics and Lonza Announce Collaboration to Develop Innovative Point-of-Care Manufacturing for TAC T-Cell Therapeutic Targeting Solid Tumors


Mar 17, 2020

Recursion Appoints Dr. Shafique Virani as Chief Corporate Development Officer


Mar 17, 2020

NeoPhore Appoints Dr Matthew Baker as Chief Executive Officer



Mar 13, 2020

Advicenne Announces the Appointment of André Ulmann as Interim Chief Executive Officer


Mar 11, 2020

Wechsel im Vorstand von CureVac: Unternehmensgründer Ingmar Hoerr folgt auf CEO Daniel Menichella


Mar 11, 2020

Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG


Mar 3, 2020

AB2 Bio Appoints Michael Soldan CEO


Mar 2, 2020

CureVac CEO Daniel Menichella Discusses Coronavirus Vaccine Development with U.S. President Donald Trump and Members of Coronavirus Task Force



Feb 26, 2020

Nouscom Strengthens Its Management Team


Feb 18, 2020

CEOCFO Magazine interview with Machavert Pharmaceuticals CEO about taking down the KRAS cancer


Feb 17, 2020

Anima Biotech to Present at the 13th Annual European Life Sciences CEO Forum


Feb 14, 2020

Kleo Pharmaceuticals Elects CEO Doug Manion, MD, FCRP (C), New Chairman of the Board


Feb 10, 2020

NeuroRx: Phase 3 Drug for Suicidal Bipolar Depression to Present at BIO CEO Conference



Feb 7, 2020

Incysus Therapeutics to Present at the 2020 BIO CEO and Investor Conference


Feb 6, 2020

Landos Biopharma to Present at the Annual BIO CEO and Investor Conference


Feb 6, 2020

Anima Biotech to Present at the BIO CEO and Investor Conference


Feb 5, 2020

Kineta Invited to Participate at the BIO CEO and Investor Conference


Feb 4, 2020

Samus Therapeutics to Present at BIO CEO and Investor Conference



Feb 4, 2020

AZTherapies to Present at 22nd Annual BIO CEO and Investor Conference


Feb 4, 2020

SmartPharm Therapeutics Announces Presentation at the 2020 BIO CEO and Investor Conference


Feb 4, 2020

Viracta Therapeutics to Present at the 2020 BIO CEO and Investor Conference


Feb 3, 2020

Cerevance to Present at the BIO CEO and Investor Conference


Feb 3, 2020

OpSec Security Appoints Selva Selvaratnam CEO



Jan 29, 2020

Decibel Therapeutics Announces Leadership Transition


Jan 28, 2020

Century Therapeutics Expands Board of Directors and Management Team


Jan 28, 2020

Passage Bio Appoints Bruce Goldsmith, Ph.D. as Chief Executive Officer


Jan 28, 2020

John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer


Jan 13, 2020

PanTheryx Announces New CEO and Chairman



Jan 13, 2020

DNAtrix Appoints Jeff Knapp as Chief Executive Officer and to Board of Directors


Jan 13, 2020

Rafael Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference


Jan 13, 2020

Dyne Therapeutics Announces Appointment of Molly White as Vice President, Medical Communications and Advocacy


Jan 13, 2020

Ginkgo Bioworks CEO to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 8, 2020

Intensity Therapeutics to Participate in East/West CEO Conference



Jan 7, 2020

ImmunityBio to Present at the 38th Annual J.P. Morgan Healthcare Conference


Dec 20, 2019

Lodo Therapeutics Names Serial Biotech Entrepreneur Dale Pfost As CEO And Adds Top Industry Veterans To Leadership Team


Dec 18, 2019

The Mitchell Thorp Foundation Selects Calidi Biotherapeutics CEO to Receive the Pillars of Hope Award


Dec 18, 2019

Jeffrey Goldberg Appointed Chief Executive Officer and Director of Immunitas Therapeutics


Dec 17, 2019

Triplet Therapeutics Launches with $59 Million in Financing to Further its Development of Transformative Treatments for Triplet Repeat Disorders



Dec 12, 2019

Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease


Dec 11, 2019

Pyxis Oncology Appoints Lara Sullivan, M.D. as Chief Executive Officer and Director


Dec 10, 2019

Locana Expands Leadership Team with Appointment of former Casebia CEO, James Burns, Ph.D., as Chief Executive Officer


Dec 5, 2019

Black Diamond Therapeutics Closes $85 Million Series C Financing


Dec 4, 2019

Nuvelution Pharma Appoints Ronald Martell as President and CEO



Dec 3, 2019

Caraway Therapeutics Expands Leadership Team With Appointment of Martin D. Williams, MS, MBA, as Chief Executive Officer and Cristina Csimma, PharmD, MHP, as Chair of the Board of Directors


Dec 2, 2019

IFM Therapeutics Announces $55.5 Million Financing to Launch and Fund New Subsidiaries and Appointment of Dr. H. Martin Seidel as Chief Executive Officer


Dec 2, 2019

Amphivena Appoints Dr. Curtis L. Ruegg as President and Chief Executive Officer


Nov 21, 2019

Arrakis Therapeutics Appoints Katrine Bosley as Chairman of the Board of Directors


Nov 21, 2019

Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO



Nov 20, 2019

Kymera Therapeutics Promotes Nello Mainolfi, PhD, to Chief Executive Officer


Nov 19, 2019

Aruvant Appoints William Chou as Chief Executive Officer


Nov 14, 2019

Diverse Biotech announces appointment of new Chief Executive Officer (CEO) - Stella Vnook


Nov 7, 2019

Partner Therapeutics (PTx) Announces the Appointment of John McManus as Chief Business Officer


Nov 4, 2019

Biohaven Statement Regarding Kleo Pharmaceuticals (Kleo): Thomas J. Lynch, Jr., MD, Appointed As Kleo Chairman Of The Board



Oct 30, 2019

Third Pole Therapeutics Names Bill Athenson New CEO


Oct 30, 2019

Vedanta Biosciences CEO Receives 2019 Immigrant Entrepreneur Award


Oct 24, 2019

Sheila Mikhail, AskBio CEO and Cofounder, Named Springboard Enterprises' 2019 Northstar Honoree


Oct 21, 2019

BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as Chief Executive Officer to Lead Next Stage of Growth


Oct 21, 2019

Rheos Medicines Appoints Barbara S. Fox as Chief Executive Officer



Oct 16, 2019

Sirtex Medical appoints Kevin R. Smith as Chief Executive Officer


Oct 16, 2019

Click Therapeutics, Inc. Honored by Goldman Sachs for Entrepreneurship


Oct 9, 2019

Sirnaomics' President and CEO Patrick Lu to Give Keynote Address at RNAi China Conference


Oct 7, 2019

Sojournix CEO Speaks Today at LSX World Congress USA


Oct 1, 2019

Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer



Oct 1, 2019

Dyne Therapeutics Announces Appointment of Joshua Brumm as President and Chief Executive Officer


Oct 1, 2019

Renew Biopharma Announces Landmark Patent in Cannabinoid Biosynthesis; CEO to Speak Today at SynBioBeta


Sep 27, 2019

Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform


Sep 24, 2019

Escient Pharmaceuticals Announces Appointment of K. Peter Hirth to Board of Directors


Sep 19, 2019

Vivex Biologics, Inc. announces Peter Wehrly as the new CEO of the company



Sep 9, 2019

Cerevel Therapeutics Appoints Biotechnology Leader Tony Coles, M.D., as Chief Executive Officer


Sep 6, 2019

Step Pharma Appoints Seasoned Drug Developer Dr. Andrew Parker as Chief Executive Officer


Sep 4, 2019

Bolt Biotherapeutics Appoints Veteran Executive Randall Schatzman as CEO to Lead the Next Phase of Growth


Sep 3, 2019

Accent Therapeutics Appoints Shakti Narayan as Chief Executive Officer


Sep 3, 2019

Macrophage Pharma Appoints Dr Søren Bregenholt as Chief Executive Officer



Aug 26, 2019

Ulrich Thienel MD, PhD Named Chief Executive Officer of ReAlta Life Sciences, Inc.


Aug 16, 2019

Jeff Berg Assumes Top Leadership Role at AbelsonTaylor With Appointment to President


Aug 12, 2019

Kineta Invited to Participate at Solebury Trout's 9th Annual CEO Roundtable Conference


Aug 8, 2019

Palladio Biosciences Appoints Alex Martin Chief Executive Officer


Aug 7, 2019

Vor Biopharma Appoints Veteran Biotech Executive Dr. Robert Ang as President and Chief Executive Officer



Aug 2, 2019

AXON Neuroscience ernennt Michal Fresser zum CEO des Konzerns Deutsch español English Français


Aug 1, 2019

Axon Neuroscience Appoints Michal Fresser as Group CEO English español Français Deutsch


Jul 25, 2019

AgilVax Appoints Dr. Joseph Patti as Chief Executive Officer


Jul 22, 2019

Disarm Therapeutics Announces Appointment of Dr. Alvin Shih as President and Chief Executive Officer


Jul 17, 2019

Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer



Jul 11, 2019

Juvenescence announces appointment of Colin Watts as CEO of Juvenescence Life


Jul 10, 2019

Yumanity Therapeutics Appoints Richard Peters, M.D., Ph.D., as Chief Executive Officer


Jun 25, 2019

SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer


Jun 19, 2019

HemoShear Therapeutics Names Biopharma Veteran Kathleen M. Metters, PhD, to Board of Directors


Jun 18, 2019

Maze Therapeutics Appoints Jason Coloma as Chief Executive Officer and Expands Leadership Team



Jun 17, 2019

Alcresta Therapeutics Announces Appointment of Daniel Orlando as Chief Executive Officer


Jun 11, 2019

Celsius Therapeutics Appoints Tariq Kassum, M.D., as Chief Executive Officer


Jun 11, 2019

ReViral Appoints Alex C. Sapir as Chief Executive Officer


Jun 6, 2019

Sanjeev Luther, President and CEO of Rafael Pharmaceuticals, Named Finalist for The 2019 EY Entrepreneur Of The Year® Award in New Jersey


Jun 3, 2019

Lyndra Therapeutics Welcomes Dr. Patricia Hurter as Chief Executive Officer



May 28, 2019

Nanobiotix Announces the Launch of Curadigm: a New Nanotechnology Platform for Healthcare


May 28, 2019

Medeor Therapeutics Appoints Dr. Karen Smith as President and Chief Executive Officer


May 25, 2019

WindMIL Therapeutics Appoints Donald J. Hayden, Jr., as CEO


May 23, 2019

ZyVersa Therapeutics Announces Appointment of International Investor, Andrew (DW) Kim, to its Board of Directors


May 22, 2019

Akrevia Therapeutics Appoints René Russo, PharmD, as Chief Executive Officer



May 18, 2019

Talaris Therapeutics, Inc. Announces $100M Series A Financing to Advance Its Novel, Allogeneic Cell Therapy Through Late-Stage Clinical Development


May 16, 2019

Sanjeev Luther, President and CEO of Rafael Pharmaceuticals, to be Honored by American Cancer Society at Annual Starry Night Gala


May 13, 2019

AEON Biopharma Appoints BOTOX Therapeutic Head as President and Chief Executive Officer USA - English USA - English


May 8, 2019

Kymab Appoints Pharmaceutical Veteran Simon Sturge as Chief Executive Officer


May 3, 2019

Dr. Thomas Ichim Appointed President and Chief Executive Officer of Batu Biologics Inc.



Apr 30, 2019

Adicet Bio Appoints Anil Singhal Chief Executive Officer


Apr 18, 2019

Obsidian Therapeutics Announces Leadership Transition and Appoints Paul K. Wotton, Ph.D., as Chief Executive Officer


Apr 18, 2019

Arrakis Therapeutics Announces $75 Million Series B Financing to Advance a New Class of Small-Molecule Medicines Targeting RNA


Apr 8, 2019

IGF Oncology Appoints Gary G. Altman, Ph.D., as Chief Executive Officer


Mar 29, 2019

General Paul J. Selva Joins USO for Final Senior Military Tour as Vice Chairman of the Joint Chiefs of Staff



Mar 28, 2019

Xcovery Announces the Appointment of Li Mao as Chief Executive Officer and Giovanni Selvaggi as Chief Medical Officer


Mar 27, 2019

Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer


Mar 21, 2019

FORMA Therapeutics Announces Frank D. Lee as Chief Executive Officer


Mar 21, 2019

Mirum Pharmaceuticals Appoints Chris Peetz as Chief Executive Officer


Mar 20, 2019

NeoPhore Appoints Dr John Haurum as Non-Executive Director



Mar 18, 2019

RDD Pharma Appoints John Temperato as Chief Executive Officer


Mar 15, 2019

Vycellix CEO to Present Strategies for Enhancing Next-Generation NK Cell Cancer Therapy at Innate Killer Summit


Mar 14, 2019

VenatoRx Pharmaceuticals’ Christopher J. Burns, Ph.D. Named CEO of the Year by Life Sciences Pennsylvania


Mar 5, 2019

Innocoll Holdings Limited Appoints Richard Fante as Chief Executive Officer


Feb 25, 2019

Viriom Announces New CEO Appointment



Feb 24, 2019

GigaGen CEO David Johnson to Present on Surge Technology at 2019 Antibody Engineering & Therapeutics Asia Meeting


Feb 22, 2019

Anima Biotech to Present at the 12th Annual European Life Sciences CEO Forum


Feb 14, 2019

Cadent Therapeutics Appoints Jodie Morrison as Chief Executive Officer


Feb 7, 2019

Anima Biotech to Present at the 21st Annual BIO CEO and Investor Conference 2019


Feb 6, 2019

VenatoRx Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference



Feb 6, 2019

Kleo Pharmaceuticals to Present at 2019 BIO CEO and Investor Conference in New York City


Feb 6, 2019

VenatoRx Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference


Feb 5, 2019

Graybug Vision Appoints Frédéric Guerard as Chief Executive Officer


Feb 5, 2019

NanOlogy Chief Medical Officer on Panel to Discuss Next Wave of Innovation in IO Therapy at BIO CEO & Investor Conference


Feb 5, 2019

Sensei Biotherapeutics to Present at BIO CEO & Investor Conference



Feb 5, 2019

Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference


Feb 5, 2019

Sensei Biotherapeutics to Present at BIO CEO and Investor Conference


Feb 5, 2019

NanOlogy Chief Medical Officer on Panel to Discuss Next Wave of Innovation in IO Therapy at BIO CEO and Investor Conference


Feb 4, 2019

Tarveda Therapeutics to Present at the 2019 BIO CEO & Investor Conference


Feb 4, 2019

Tarveda Therapeutics to Present at the 2019 BIO CEO and Investor Conference



Feb 4, 2019

Anima Biotech Featured at the 5th Annual LSX World Congress


Jan 30, 2019

Sirnaomics to Present at 2019 BIO CEO & Investor Conference


Jan 30, 2019

Knopp Biosciences to Present at 2019 BIO CEO & Investor Conference


Jan 30, 2019

Knopp Biosciences to Present at 2019 BIO CEO and Investor Conference


Jan 29, 2019

Propanc Biopharma to Present at the 2019 BIO CEO and Investor Conference



Jan 28, 2019

Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO


Jan 28, 2019

Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President and CEO


Jan 24, 2019

Oyster Point Pharma to Present at the BIO CEO & Investor Conference


Jan 24, 2019

Oyster Point Pharma to Present at the BIO CEO and Investor Conference


Jan 17, 2019

eGenesis Appoints Industry Veteran Paul Sekhri as President and Chief Executive Officer



Jan 15, 2019

ArunA Bio Appoints Dr. Mark Sirgo as Chief Executive Officer


Jan 15, 2019

Questionmark CEO Eric Shepherd Steps Down after 18 Years


Jan 9, 2019

Vascular Therapies Appoints John McDermott as Chief Executive Officer


Jan 9, 2019

Agilvax Elects Dr. David T. Hung, Former Founder and CEO of Medivation, to Its Board of Directors


Jan 8, 2019

Cygnal Therapeutics Appoints Pearl S. Huang as Chief Executive Officer



Jan 4, 2019

ViaCyte Provides Update on Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications


Jan 4, 2019

Immunocore Appoints Bahija Jallal as Chief Executive Officer


Jan 4, 2019

Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines


Jan 3, 2019

StrideBio Appoints Sapan Shah, Ph.D. as Chief Executive Officer


Jan 3, 2019

TARIS Appoints Tony Kingsley as President and Chief Executive Officer



Jan 3, 2019

Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals


Jan 3, 2019

Amunix Announces Appointment of Dr. Angie You as Chief Executive Officer and Dr. Rich Heyman as Chairman of the Board of Directors


Jan 3, 2019

Tizona Therapeutics Appoints Scott Clarke as Chief Executive Officer and Provides Update on Regulatory Milestone for its First-in-Class CD39 program in Cancer


Dec 13, 2018

Jeff Jonker Joins Ambys Medicines as President and CEO


Dec 12, 2018

Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing



Dec 7, 2018

GigaGen CEO David Johnson to Present at 2018 Antibody Engineering & Therapeutics Meeting


Dec 6, 2018

XyloCor Therapeutics Raises $17 Million in Series A Financing to Advance Gene Therapy Portfolio in Cardiovascular Disease


Nov 20, 2018

ImmusanT CEO Leslie Williams to Present at Multiple Life Sciences Events to Share Company’s Leadership Position in the Industry and Successful Growth Strategy


Nov 12, 2018

GigaGen CEO David Johnson to Present on Development of Recombinant Polyclonal Therapies for Infectious Disease at 10th Annual PEGS Summit Europe


Nov 6, 2018

Jnana Therapeutics Announces Appointment of Joanne Kotz, Ph.D. as Chief Executive Officer



Oct 25, 2018

FogPharma Appoints Dr. Barbara Weber to its Board of Directors


Oct 23, 2018

Immunomic Therapeutics CEO to Present at NYC Oncology Investor Conference


Oct 23, 2018

ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases


Oct 23, 2018

OncoImmune Announces Presentation of CD24Fc Phase IIa Data and Phase III Clinical Trial Design at the 2020 Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR


Oct 23, 2018

Forbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by Roche



Oct 15, 2018

F-star Appoints Dr Eliot Forster as Chief Executive Officer


Oct 4, 2018

Nimbus Therapeutics Names Jeb Keiper as President and Chief Executive Officer


Oct 3, 2018

BlueRock Therapeutics President and CEO Emile Nuwaysir elected to serve as Vice Chairman of the Alliance for Regenerative Medicine


Oct 3, 2018

Immunomic Therapeutics CEO to Join Panel at 18th Annual Biotech in Europe Forum


Oct 3, 2018

Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer



Oct 2, 2018

European Wax Center Appoints David P. Berg as Chief Executive Officer


Oct 1, 2018

NGM Bio Appoints David J. Woodhouse, Ph.D. as Chief Executive Officer and Aetna Wun Trombley, Ph.D. as President and Chief Operating Officer


Oct 1, 2018

Tomorrow: Immunomic Therapeutics CEO at Outsourcing in Clinical Trials Mid-Atlantic


Oct 1, 2018

Renew Biopharma CEO Michael Mendez to Speak at SynBioBeta 2018


Sep 27, 2018

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture



Sep 26, 2018

Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Executive Officer


Sep 25, 2018

Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer


Sep 24, 2018

NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer


Sep 24, 2018

Immunomic Therapeutics CEO to Present at Precision Medicine World Conference (PMWC): Emerging Therapeutics Showcase


Sep 12, 2018

MPM Capital and Versant Ventures Launch CODA Biotherapeutics to Accelerate Development of Chemogenetic Gene Therapy Platform



Sep 11, 2018

Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer


Sep 11, 2018

Imara Announces CEO Rahul Ballal, Ph.D., Will Present at the 7th Annual Sickle Cell Disease Therapeutic Conference


Sep 7, 2018

Rani Therapeutics' CEO Mir Imran Selected for the 2018 Upstart 50 List


Sep 6, 2018

Rheos Medicines Appoints Sanjay Keswani as Chief Executive Officer to Lead Company’s Pioneering Drug Development in Immunometabolism


Sep 5, 2018

SpringWorks Therapeutics Announces Appointment of Saqib Islam as Chief Executive Officer



Aug 29, 2018

Immunomic Therapeutics CEO to Present at Immuno-Oncology Summit


Aug 23, 2018

E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer


Aug 21, 2018

Allegro Ophthalmics Prepares To Take Lead Compound Risuteganib To Phase 3, Appoints New CEO


Aug 15, 2018

Karuna Appoints Seasoned Biopharma Veteran Steven Paul, M.D., as Chief Executive Officer


Aug 14, 2018

Sigilon Therapeutics Announces Leadership Transition and Appoints Rare Disease Pioneer Rogerio Vivaldi, M.D., as Chief Executive Officer



Aug 8, 2018

Rani Therapeutics' CEO Named PharmaVOICE 100 Honoree


Aug 2, 2018

Navitor Pharmaceuticals Appoints Thomas E. Hughes, Ph.D. as Chief Executive Officer


Aug 2, 2018

Enterome CEO to Present at Two Upcoming Investor Conferences in the United States


Aug 1, 2018

Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation


Aug 1, 2018

Oncorus®, Inc., Names Industry Veteran Ted Ashburn as new President and CEO



Aug 1, 2018

BioAxone BioSciences CEO Lisa McKerracher Speaker at NeuroTrauma2018 Conference


Aug 1, 2018

Genome Editing Biotech EdiGene Names Dong Wei, Ph.D., MBA as its Chief Executive Officer


Jul 30, 2018

Tenaya Therapeutics Appoints Faraz Ali as Chief Executive Officer


Jul 26, 2018

MedDay Appoints Industry Leader Christian Chavy as Chief Executive Officer


Jul 17, 2018

Neurana Pharmaceuticals Appoints Craig Thompson as President and CEO



Jul 17, 2018

APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer


Jul 16, 2018

enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President


Jun 27, 2018

Verge Genomics' CEO Alice Zhang Named to MIT Technology Review's 2018 Innovators Under 35 List


Jun 19, 2018

Humacyte Appoints Jeffrey Lawson MD, PhD as President and Chief Executive Officer


Jun 13, 2018

Imara Appoints Rahul D. Ballal, Ph.D., as Chief Executive Officer



Jun 12, 2018

Aura Biosciences Earns CEO Cancer Gold Standard Accreditation


Jun 12, 2018

NIH awards Arrevus STTR grant for UTI research, CEO to speak at IMAP 2018


Jun 5, 2018

Harry Leider, Former Chief Medical Officer of Walgreens, Joins Gelesis as Chief Medical Officer, and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, Joins the Gelesis Board of Directors


May 27, 2018

Context Therapeutics Co-Founder and CEO Martin Lehr Named Ernst & Young 2018 Entrepreneur of the Year Semifinalist


May 27, 2018

Alexander Gebauer Joins Executive Board of OMEICOS Therapeutics and Named CEO and Chairman of OMEICOS Ophthalmics



May 27, 2018

Lyndra Inc. and Global Drug Commercialization Center Announce Joint Venture to Develop Lyndra’s Ultra-Long-Acting Oral Dosage Form for Chinese Market


May 27, 2018

Context Therapeutics Co-Founder and CEO Martin Lehr Named Ernst and Young 2018 Entrepreneur of the Year Semifinalist


May 24, 2018

ImmusanT CEO Leslie Williams to Discuss Immunology of Celiac Disease at 2018 BIO International Convention


May 23, 2018

Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of RandD for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing


May 19, 2018

Atreca Announces John A. Orwin Appointed President and CEO



May 16, 2018

Sensei Biotherapeutics Appoints John Celebi as President and Chief Executive Officer


May 14, 2018

Complexa Appoints Francisco D. Salva Chief Executive Officer and President


May 10, 2018

Semma Therapeutics Appoints Bastiano Sanna, Ph.D. as Chief Executive Officer and President


May 3, 2018

C4 Therapeutics Announces Appointment of Andrew Phillips, Ph.D. as President and Chief Executive Officer


Apr 30, 2018

GigaGen CEO David Johnson to Present on the Power of Surge Technology to Discover Unique Immuno-oncology Antibodies at 14th Annual PEGS Summit



Apr 23, 2018

OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer


Apr 11, 2018

AIVITA Biomedical CEO Hans Keirstead to Deliver Plenary Keynote at GTCbio's 15th Stem Cell Summit


Apr 9, 2018

GigaGen CEO David Johnson to Present Data from Surge Platform at American Association for Cancer Research Annual Meeting 2018


Apr 4, 2018

Surrozen Strengthens Leadership Team with Addition of New CEO and Scientific Co-founder


Mar 29, 2018

Corvidia Therapeutics Appoints Marc de Garidel as Chief Executive Officer



Mar 28, 2018

Meissa Vaccines' Cofounder and CEO Dr. Martin Moore to Present at World Vaccine Congress


Mar 15, 2018

Batu Biologics Chief Executive Officer Samuel Wagner to Moderate Congressional Immunotherapy Symposium


Mar 6, 2018

Adicet Bio Announces the Transition of Founder, President and Chief Executive Officer Dr. Aya Jakobovits


Feb 13, 2018

Amunix CEO to deliver keynote address on ProTIA, Amunix’s novel immuno-oncology technology, at the Biologics and Biosimilars Congress Europe (March 2018)


Feb 12, 2018

OncoQuest to Present at BIO CEO and Investor Conference



Feb 12, 2018

Remedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory Board


Feb 8, 2018

Atreca to Participate at the 2018 BIO CEO & Investor Conference


Feb 8, 2018

Saghmos Therapeutics to Present at BIO CEO Conference in New York


Feb 8, 2018

Lakewood-Amedex, Inc. to Present at 2018 BIO CEO and Investor Conference


Feb 8, 2018

Atreca to Participate at the 2018 BIO CEO and Investor Conference



Feb 5, 2018

Tarveda Therapeutics to Present at the 2018 BIO CEO & Investor Conference


Feb 5, 2018

NanOlogy to Update Clinical Program Transforming Treatment of Cancer at BIO CEO and Investor Conference


Feb 5, 2018

Tarveda Therapeutics to Present at the 2018 BIO CEO and Investor Conference


Feb 1, 2018

Chrono Therapeutics Announces Appointment of David Happel as Chief Executive Officer


Jan 31, 2018

OrphoMed to Present at the 2018 BIO CEO and Investor Conference



Jan 18, 2018

Anokion Announces Appointment of Dr. John Hohneker as Chief Executive Officer


Jan 10, 2018

Propanc Biopharma Engages Alan Morell of Creative Management Partners as Senior Strategic Advisor to CEO and Board of Directors


Jan 8, 2018

sterna biologicals Appoints Christian Pangratz as Chief Executive Officer


Jan 5, 2018

ViaCyte Announces First Patients Implanted in Cohort 2 with Potentially Efficacious Dose of PEC-Direct Islet Cell Replacement Therapy


Jan 5, 2018

KBP Biosciences Raises $76 Million in Series A Financing and Appoints Brian P. McVeigh as Chief Executive Officer



Jan 5, 2018

Bonti to Present at Two Prestigious Healthcare Conferences


Jan 4, 2018

PellePharm Appoints Sanuj K. Ravindran, M.D., as President and Chief Executive Officer


Jan 4, 2018

Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept


Jan 4, 2018

AOBiome Therapeutics Appoints Todd Krueger as Chief Executive Officer


Dec 14, 2017

GigaGen CEO David Johnson to Present at 2017 Antibody Engineering & Therapeutics Meeting



Dec 12, 2017

Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer


Dec 6, 2017

Bicycle Therapeutics and Cancer Research UK Named Best Partnership Alliance of the Year at 2017 Scrip Awards


Nov 28, 2017

Fibrocor Therapeutics Appoints Its First President and CEO


Nov 21, 2017

Cancer Prevention Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference


Nov 15, 2017

Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension



Nov 13, 2017

Evox Therapeutics Appoints Antonin de Fougerolles as Chief Executive Officer


Nov 9, 2017

Northern Biologics Announces CEO Transition


Nov 8, 2017

Cognition Therapeutics CEO Kenneth I. Moch to Present at the Stifel 2017 Healthcare Conference


Nov 6, 2017

STORM Therapeutics Strengthens Board with Appointment of Professor Paul Workman, President and CEO of The Institute of Cancer Research


Oct 12, 2017

Gadeta Strengthens Executive Management Team with the Appointments of Shelley Margetson as CEO and Thomas Davis as CMO



Oct 5, 2017

Braeburn CEO Participates in U.S. Department of Health and Human Services Secretarial Roundtable Discussion on Opioids


Oct 2, 2017

KSQ Therapeutics Emerges with $76 Million in Financing to Pioneer High-Confidence Drug Development


Sep 25, 2017

Tango Therapeutics Appoints Barbara Weber, M.D., as Chief Executive Officer


Sep 20, 2017

Cognition Therapeutics CEO Kenneth I. Moch to Present at Ladenburg Thalmann 2017 Healthcare Conference


Sep 19, 2017

Juvenescence Limited CEO Delivers Keynote Speech on Anti-Ageing Drug Development at Basel Life/EMBO 8Th Annual Global Healthcare Conference; Notice of Future Conferences



Sep 18, 2017

Telephus Medical LLC Announces CEO Mark Benedyk, PhD to Serve on Panel "Advances Against Rare and Resistant Pathogens" at Anti-Infectives Rx Invitation-Only Conference


Sep 15, 2017

Neovii Pharmaceuticals AG Announces New CEO España - español USA - English France - Français


Sep 7, 2017

Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer


Sep 7, 2017

Cognition Therapeutics CEO Kenneth I. Moch Hosting One-on-Ones at Mizuho Securities CNS Deep Management Day


Sep 6, 2017

Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer



Aug 10, 2017

BioAxone BioSciences CEO Lisa McKerracher Accepts Role of Consortium Advisory Panelist for the Christopher Reeve Foundation


Aug 8, 2017

Graybug Vision CEO to Participate in OIS@ASRS Conference


Jul 31, 2017

Cognition Therapeutics CEO Kenneth I. Moch to Present at Canaccord Genuity Annual Growth Conference


Jul 28, 2017

Fernand Labrie of Endoceutics Scoops Two Business Worldwide Magazine CEO Award Titles


Jul 5, 2017

Matthew Gantz Appointed CEO of OxThera



Jul 5, 2017

Matthew Gantz zum CEO von OxThera ernannt


Jul 5, 2017

Matthew Gantz Appointed CEO of OxThera USA - English Sverige - Svenska France - Français España - español Deutschland - Deutsch


Jun 27, 2017

Dr. Joan Fallon, CEO of Curemark, Named EY Entrepreneur Of The Year 2017 New York Award Winner


Jun 9, 2017

Kleo Pharmaceuticals Inc. Appoints Douglas J. Manion M.D. as Chief Executive Officer


Jun 6, 2017

Dr. Joan Fallon, CEO Of Curemark, Named EY Entrepreneur Of The Year 2017 Award Finalist In New York



Jun 5, 2017

Braeburn Pharmaceuticals Names Michael M. Derkacz as President and CEO


May 24, 2017

Karolinska Development company Modus Therapeutics announces appointment of Ellen K. Donnelly, Ph.D. as CEO


May 24, 2017

Karolinska Development company Modus Therapeutics announces appointment of Ellen K. Donnelly, Ph.D. as CEO


May 23, 2017

BioAxone BioSciences CEO Lisa McKerracher Invited Speaker at the 12th Annual Neurotech Investing and Partnering Conference, Orphan Disease Panel


May 19, 2017

ReForm Biologics Appoints John M. Sorvillo, Ph.D., as Chief Executive Officer



May 18, 2017

Xontogeny, a New Accelerator Operating Company, Launches with a $25 Million Series A Financing to Advance Early Stage Life Sciences Technology through Clinical Proof-of-Concept


May 12, 2017

Cardior Pharmaceuticals zamelt € 15 miljoen in en benoemd CEO en CSO Nederland - Nederlands France - Français Deutschland - Deutsch


May 6, 2017

Innocrin Pharmaceuticals Appoints Fred Eshelman, PharmD as CEO and is Granted Fast Track Designation by FDA for Seviteronel Treatment of Women with Triple-negative Breast Cancer and Women or Men with Estrogen Receptor-positive Breast Cancer


May 4, 2017

Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer


May 3, 2017

Cognition Therapeutics CEO Kenneth I. Moch Presenting at BioCentury Future Leaders Conference



May 2, 2017

ImCheck Therapeutics raises €20 Million and appoints its CEO


May 2, 2017

CureVac Appoints Daniel Menichella as CEO of CureVac Inc., the Company's US Subsidiary


May 1, 2017

Fiesta Restaurant Group, Inc. Appoints Nicholas P. Shepherd and CEO Richard C. Stockinger to Board of Directors


Apr 26, 2017

Proclara Biosciences Appoints Suzanne Bruhn, Ph.D., as Chief Executive Officer to Guide Development of Novel Approach for Neurodegenerative Diseases


Apr 3, 2017

AIVITA Biomedical CEO Hans Keirstead, Ph.D. to Present as Distinguished Speaker at Upcoming Stem Cell Summit 2017



Mar 27, 2017

Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer


Mar 7, 2017

Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer


Feb 27, 2017

Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Michael Gilman Chairman and CEO


Feb 10, 2017

NeuroRx to Present at the BIO CEO & Investor Conference on February 13


Feb 10, 2017

NeuroRx to Present at the BIO CEO & Investor Conference on February 13



Feb 10, 2017

NeuroRx to Present at the BIO CEO and Investor Conference on February 13


Feb 10, 2017

iTeos Therapeutics to Present at the 2017 BIO CEO and Investor Conference


Feb 9, 2017

Centrexion Therapeutics to Present at the 19th Annual BIO CEO & Investor Conference


Feb 9, 2017

Centrexion Therapeutics to Present at the 19th Annual BIO CEO and Investor Conference


Feb 7, 2017

BlackThorn Therapeutics Names Biotech Industry Veteran Gregory Vontz as Chief Executive Officer



Feb 6, 2017

Symic Bio to Present at Upcoming Conferences


Feb 6, 2017

Rebiotix to Present at BIO CEO & Investor Conference


Feb 3, 2017

Graybug Vision CEO Jeffrey Cleland Discusses Company's Prodrug Technology at Glaucoma 360 on February 3


Feb 2, 2017

Nohla Therapeutics Appoints Kathleen Fanning as President and Chief Executive Officer


Jan 23, 2017

Neuropore Therapies Announces Appointment of Dr. Errol De Souza as President and Chief Executive Officer



Jan 19, 2017

ArmaGen Appoints Mathias Schmidt, Ph.D., as Chief Executive Officer


Jan 11, 2017

Dragonfly Therapeutics Adds Technology Investor and Leading Advertising Company CEO to its Board of Directors


Jan 6, 2017

Intarcia Therapeutics Announces Upcoming Presentation at 35th Annual J.P. Morgan Healthcare Conference


Jan 5, 2017

Amplyx Pharmaceuticals Appoints Ciara Kennedy, Ph.D., as President and Chief Executive Officer


Jan 5, 2017

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing



Jan 3, 2017

Symic Bio to Participate in the 2017 East/West CEO Conference


Dec 7, 2016

Tmunity Therapeutics Names Usman “Oz” Azam Chief Executive Officer


Nov 21, 2016

Braeburn Pharmaceuticals and CEO Behshad Sheldon Win Stevie Awards for Best New Product or Service and Female Executive of the Year


Nov 1, 2016

Casebia Therapeutics Announces Appointment of James W. Burns, Ph.D. as President and Chief Executive Officer


Oct 28, 2016

Alzheimer's Drug Development Company Cognition Therapeutics appoints Kenneth I. Moch President and CEO



Oct 19, 2016

Kineta CEO Unveils Its Immuno-oncology Program at the BIO Investor Forum


Oct 17, 2016

Enterprise Therapeutics Appoints Dr John Ford as CEO


Oct 11, 2016

Lorenzo Bosisio Appointed CEO of EffRx Pharmaceuticals


Oct 6, 2016

Novaliq Strengthens Executive Management Team by Appointing Christian Roesky, PhD, as Chief Executive Officer


Sep 26, 2016

Caribou Biosciences’ President and CEO Rachel Haurwitz Named to Fortune’s 2016 “40 under 40” List of Most Influential Young People in Business



Sep 22, 2016

Kleo Pharmaceuticals Inc. Appoints David A. Spiegel as Chief Executive Officer


Sep 14, 2016

Metacrine Announces Appointment of Dr. Ken Song as President and Chief Executive Officer


Aug 18, 2016

Symphogen’s Founding CEO Kirsten Drejer Steps Down and Becomes Executive Director


Aug 11, 2016

Enterome to Present at the 6th Annual Trout Group Hamptons CEO Roundtable Conference on August 18th


Jul 13, 2016

Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer



Jul 13, 2016

Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer


Jun 23, 2016

Leading BioSciences Appoints Greg Doyle as Chief Executive Officer


Jun 1, 2016

ERS Genomics Appoints Eric Rhodes as Chief Executive Officer


May 24, 2016

Symic to Present at the Boston Biotech CEO Conference


May 2, 2016

Vycellix’s CEO to Present Novel Approaches to Adoptive Cancer Immunotherapy at Innate Killer Summit



Apr 25, 2016

Immunomic Therapeutics (ITI) Delivering Closing Keynote Address at Wharton DC Innovation Summit


Apr 18, 2016

Immunomic Therapeutics (ITI) Featured at Maryland Regional Biotech Forum


Apr 8, 2016

Avion Pharmaceuticals, LLC, announces appointment of new Chief Executive Officer


Apr 5, 2016

Intarcia Appoints Anthony Hurley as VP, Global Commercial Manufacturing and Operations, Reporting To Chairman and CEO Kurt Graves


Mar 29, 2016

Immunomic Therapeutics (ITI) and Lysosomal Associated Membrane Protein (LAMP) Based Nucleic Acid Immunotherapy Featured At 2016 World Vaccine Congress



Mar 11, 2016

Bantam Pharmaceutical Appoints Dr. Michael Luther President and CEO


Mar 10, 2016

Sirenas CEO Eduardo Esquenazi, Ph.D., to Deliver Keynote Presentation at 2016 Gordon Research Conference on Marine Natural Products


Feb 8, 2016

Intarcia Appoints Dr. John Yee into New Role of VP, Global Medical Affairs, Safety and Operations, Reporting Directly to Chairman and CEO Kurt Graves


Feb 5, 2016

Atreca, Inc. to Present at the 18th Annual BIO CEO & Investor Conference


Feb 5, 2016

Atreca, Inc. to Present at the 18th Annual BIO CEO and Investor Conference



Feb 3, 2016

EnGeneIC Ltd. to Present at BIO CEO and Investor Conference 2016


Feb 2, 2016

Symic to Present at the 18th Annual BIO CEO & Investor Conference


Feb 2, 2016

Symic to Present at the 18th Annual BIO CEO and Investor Conference


Jan 25, 2016

Emmaus Life Sciences Announces Reappointment of Dr. Yutaka Niihara as CEO


Jan 25, 2016

EnGeneIC Ltd. Strengthens Board of Directors to Support U.S. Expansion



Jan 7, 2016

C4 Therapeutics Launches with $73 Million Series A Financing


Dec 16, 2015

Decibel Therapeutics Appoints Jeff Jonas, M.D., CEO of SAGE Therapeutics, to its Board of Directors


Dec 10, 2015

Alzheon Appoints Former GlaxoSmithKline CEO Jean-Pierre Garnier as Chairman of Board of Directors


Nov 3, 2015

Neurogastrx Appoints Baxter Phillips III as President and Chief Executive Officer


Oct 19, 2015

Curemark CEO Dr. Joan Fallon To Be Featured Speaker At Two Scientific Conferences



Oct 6, 2015

Rodin Therapeutics Appoints Adam J. Rosenberg as Chief Executive Officer


Sep 22, 2015

Curemark CEO Joan Fallon To Present Power Talk At Athena Center For Leadership Studies September 29


Sep 21, 2015

leon-nanodrugs GmbH Starts U.S. Operations and Appoints Industry Veteran Theron (Ted) Odlaug as Chief Executive Officer


Sep 17, 2015

Planet Fitness Appoints David P. Berg To Board Of Directors


Sep 3, 2015

Faraday Pharmaceuticals Announces the Appointment of Dr. Stephen A. Hill as Chief Executive Officer



Aug 31, 2015

FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925


Aug 17, 2015

Tivorsan Pharmaceuticals Names Business Leader James E. Connolly as CEO and Board Member


Jul 22, 2015

Izun Pharmaceuticals Corp Appoints Jack Talley as Chief Executive Officer


Jul 21, 2015

Dauntless Pharmaceuticals Launches New Company Focused on Developing a Portfolio of Improved Therapeutics


Jul 8, 2015

Medicines360 Names Jessica Grossman as CEO



Jul 7, 2015

Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award


Jun 22, 2015

ADC Therapeutics Appoints Dr. Chris Martin as Chief Executive Officer


May 19, 2015

CutisPharma Names Neal Muni As Chief Executive Officer


May 15, 2015

Intarcia Named To "CNBC Disruptor 50" List: One Of Only Two Biopharma Companies Named


May 5, 2015

OMEICOS Appoints Dr. Ulrich Dauer as Chief Executive Officer



Mar 31, 2015

Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer


Mar 13, 2015

President & CEO Leen Kawas, PhD of M3 Biotechnology, Inc. to Be Interviewed Live on Clear Channel's "The Trader's Network Show"


Feb 9, 2015

MicroBiome Therapeutics Receives Notice Of Allowance For U.S. Patent Covering Glyceollin As A Treatment For Diabetes And Obesity


Feb 4, 2015

EnGeneIC to Present at BIO CEO and Investor Conference 2015


Feb 4, 2015

Rigontec GmbH Appoints Dr. Christian Schetter as CEO



Feb 3, 2015

Lycera Names Life Sciences Veteran Paul Sekhri as President and Chief Executive Officer


Feb 2, 2015

Lycera to Present at the 17th Annual BIO CEO & Investor Conference


Jan 7, 2015

AgeneBio CEO Jerry McLaughlin to Present at Biotech Showcase 2015


Dec 15, 2014

€6 Million in New Capital and New CEO for Cristal Therapeutics


Dec 8, 2014

Innocoll AG Appoints Tony Zook as Chief Executive Officer as Company Progresses Toward Becoming a Fully-Integrated Commercial Company



Nov 18, 2014

Curemark CEO Receives 2014 Gold Maverick of the Year Recognition at The Stevie Awards for Women in Business


Sep 29, 2014

TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend


Sep 18, 2014

Nurix, Inc. Names Arthur T. Sands, M.D., Ph.D., Chief Executive Officer


Sep 10, 2014

Agilis Biotherapeutics Names Dr. Mark J. Pykett as President and Chief Executive Officer


Sep 4, 2014

ACLI Responds To New SIFI Designation



Jul 2, 2014

Batu Biologics Appoints Biotechnology Industry Veteran, Dr. Alan Lewis, to Scientific Advisory Board


May 14, 2014

Alcresta Appoints John H. Tucker to Chief Executive Officer


Apr 7, 2014

Icon Bioscience Announces David S. Tierney, MD Joined the Company as President and Chief Executive Officer


Mar 6, 2014

Curemark CEO Joan Fallon To Speak At 2014 SXSW Interactive Festival


Feb 18, 2014

Avillion Appoints Dr Allison Jeynes-Ellis as Chief Executive Officer



Jan 13, 2014

Intarcia CEO To Present Company Progress, Interim Phase 3 Data, And Key Milestones At J.P. Morgan


Jan 9, 2014

Avelas Biosciences Closes $6.85 Million in Series B Financing to Advance Real-Time Cancer Visualization Technology to Clinical Proof-of-Concept


Jan 7, 2014

Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer


Dec 31, 2013

George S. Zorich Named Chief Executive Officer of Agilis Biotherapeutics


Oct 16, 2013

Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO



Oct 8, 2013

Neuraltus Pharmaceuticals Names Richard L. Casey as President and Chief Executive Officer


Sep 16, 2013

Curemark CEO To Deliver Keynote Address at the BioScience Vision Summit


Sep 10, 2013

AvidBiotics Announces Research Collaboration with Full Spectrum Genetics


Aug 7, 2013

NuMe Health Becomes MicroBiome Therapeutics And Recruits New CEO


Jul 25, 2013

Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO



Jul 15, 2013

Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer


Feb 25, 2013

Gliknik Adds Incyte President and CEO Paul A. Friedman to its Board of Directors


Jan 24, 2013

Metabolix CEO to Speak at 4th Annual Next Generation Bio-Based Chemicals Summit


Jan 7, 2013

Ambrx Appoints Lawson Macartney, Ph.D., DVM, Chief Executive Officer


Jan 3, 2013

ArmaGen Technologies, Inc. Hires Biotech Executive as CEO



Oct 9, 2012

Vaxxas Appoints David Hoey as Company’s First CEO


Sep 13, 2012

Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer


Jun 15, 2012

ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer


May 15, 2012

Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer


May 2, 2012

Bicycle Therapeutics Appoints Rolf H. Günther, M.D., Ph.D. as CEO



Apr 2, 2012

Intarcia Announces Expanded Appointment for Kurt Graves as Chairman, President and Chief Executive Officer


Feb 9, 2012

Veloxis Pharmaceuticals to Present at 14th Annual BIO CEO and Investor Conference


Dec 6, 2011

Theraclone Sciences Announces Appointment of Clifford Stocks as CEO


Oct 4, 2011

Lycera Appoints Senior Life Sciences Executive Kathleen M. Metters, Ph.D., as President and Chief Executive Officer


May 2, 2011

ARMGO Pharma Inc., Announces the Appointment of Dr. Sapan Shah as CEO



Feb 17, 2011

Dr. Abraham Abuchowski of Prolong Pharmaceuticals Honored With Inaugural Tibbetts Award by the U.S. Small Business Administration


Jan 5, 2011

Mike Romanos Appointed as CEO of Crescendo Biologics


Oct 5, 2010

NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director


Sep 30, 2010

3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer


Jul 19, 2010

TARIS Appoints Sarma Duddu as President and CEO



Jun 10, 2010

Quark Pharmaceuticals Closes $10 Million Financing


Jan 6, 2009

Promedior Announces Appointment of Dominick Colangelo as Chief Executive Officer


Jul 22, 2008

Vascular Therapies LLC Appoints Samuel M. Liang as President and Chief Executive Officer


Jan 25, 2008

Bank of the West CEO Named to Presidio Trust — Michael Shepherd Gets Presidential Nod


Sep 21, 2005

Marius Silvasan, CEO Recaps the Teleplus Growth and Acquisition Strategy to Investors in London, Frankfurt and Munich